DZ BANK/PUT/FRESENIUS/20/0.1/21.03.25 Share Price

Warrant

DE000DJ03KW7

Delayed Deutsche Boerse AG 16:04:42 11/07/2024 BST
0.013 EUR -13.33% Intraday chart for DZ BANK/PUT/FRESENIUS/20/0.1/21.03.25
Current month-50.00%
1 month-37.50%
Date Price Change
11/07/24 0.013 -13.33%
10/07/24 0.015 -6.25%
09/07/24 0.016 +6.67%
08/07/24 0.015 0.00%
05/07/24 0.015 -16.67%

Delayed Quote Deutsche Boerse AG

Last update July 11, 2024 at 04:04 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying FRESENIUS SE & CO. KGAA
Issuer DZ BANK
WKN DJ03KW
ISINDE000DJ03KW7
Date issued 13/04/2023
Strike 20
Maturity 21/03/2025 (253 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.28
Lowest since issue 0.013
Spread 0.02
Spread %60.61%

Company Profile

Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - hospital administration and engineering (64.3%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (35.7%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (72.4%), North America (12.3%), Asia/Pacific (7.3%), Latin America (6.4%) and Africa (1.6%).
Sector
-
More about the company

Ratings for Fresenius SE & Co. KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius SE & Co. KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
29.01 EUR
Average target price
37.26 EUR
Spread / Average Target
+28.43%
Consensus